Suppr超能文献

自然杀伤细胞——它们在肿瘤免疫监视中的作用。

Natural Killer Cells - Their Role in Tumour Immunosurveillance.

作者信息

Sharma Preeti, Kumar Pradeep, Sharma Rachna

机构信息

Associate Professor, Department of Biochemistry, Santosh Medical University, Ghaziabad, Uttar Pradesh, India.

Professor, Department of Biochemistry, Santosh Medical University, Ghaziabad, Uttar Pradesh, India.

出版信息

J Clin Diagn Res. 2017 Aug;11(8):BE01-BE05. doi: 10.7860/JCDR/2017/26748.10469. Epub 2017 Aug 1.

Abstract

An important component of the innate immune system, the natural killer cells that originate from the lymphoid cell lineage, hold tremendous potential as an effective therapeutic tool to combat a variety of cancers. Their vast capability to kill altered cells such as opsonized cells (antibody coated), tumour cells, genotoxically changed cells without affecting the healthy cells of the body, make them an effective therapeutic agent for various types of cancers. Besides, through interplay and molecular crosstalk via several cytokines, they also augment the adaptive immune response by, promoting the differentiation, activation and recruitment of component cells of the system. With the current advance knowledge of Natural Killer (NK) cells, their receptor-ligand interactions involved in functional regulation, various mechanistic approaches involving the role of cytokines led to desired modulation of NK cell activity in a tailor-made manner, for triggering clinically relevant responces. Several strategies have been adopted by researchers, to augment the efficacy of NK cells. Still many challenges exist for increasing the therapeutic relevance of these cells.

摘要

作为先天免疫系统的一个重要组成部分,源自淋巴样细胞谱系的自然杀伤细胞,作为对抗多种癌症的有效治疗工具具有巨大潜力。它们具有强大的杀伤能力,能够杀死诸如调理素化细胞(抗体包被)、肿瘤细胞、基因毒性改变的细胞等异常细胞,而不影响身体的健康细胞,这使其成为治疗各种癌症的有效治疗剂。此外,通过几种细胞因子的相互作用和分子串扰,它们还通过促进系统组成细胞的分化、激活和募集来增强适应性免疫反应。随着目前对自然杀伤(NK)细胞的深入了解,它们在功能调节中涉及的受体-配体相互作用,以及涉及细胞因子作用的各种机制方法,使得能够以定制的方式对NK细胞活性进行所需的调节,从而引发临床相关反应。研究人员采用了多种策略来提高NK细胞的功效。然而,要提高这些细胞的治疗相关性仍然存在许多挑战。

相似文献

1
Natural Killer Cells - Their Role in Tumour Immunosurveillance.
J Clin Diagn Res. 2017 Aug;11(8):BE01-BE05. doi: 10.7860/JCDR/2017/26748.10469. Epub 2017 Aug 1.
2
Therapeutic potential and challenges of natural killer cells in treatment of solid tumors.
Front Immunol. 2015 Apr 29;6:202. doi: 10.3389/fimmu.2015.00202. eCollection 2015.
3
[Natural killer (NK) cell and immunotherapy].
Nihon Rinsho. 2017 Feb;75(2):306-311.
4
Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal .
J Virol. 2018 May 29;92(12). doi: 10.1128/JVI.00235-18. Print 2018 Jun 15.
5
Emerging role of Natural killer cells in oncolytic virotherapy.
Immunotargets Ther. 2015 Mar 31;4:65-77. doi: 10.2147/ITT.S55549. eCollection 2015.
6
Natural killer cells and cancer therapy, what we know and where we are going.
Immunotherapy. 2019 Oct;11(14):1231-1251. doi: 10.2217/imt-2019-0040. Epub 2019 Aug 19.
7
NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans.
Front Immunol. 2019 Apr 9;10:719. doi: 10.3389/fimmu.2019.00719. eCollection 2019.
8
Natural killer cells involved in tumour immune escape of hepatocellular carcinomar.
Int Immunopharmacol. 2019 Aug;73:10-16. doi: 10.1016/j.intimp.2019.04.057. Epub 2019 May 9.
9
Shaping of Natural Killer Cell Antitumor Activity by Cultivation.
Front Immunol. 2017 Apr 26;8:458. doi: 10.3389/fimmu.2017.00458. eCollection 2017.
10
Natural killer-dendritic cell cross-talk in cancer immunotherapy.
Expert Opin Biol Ther. 2005 Oct;5(10):1303-15. doi: 10.1517/14712598.5.10.1303.

引用本文的文献

2
The evolution of cancer immunotherapy: a comprehensive review of its history and current perspectives.
Korean J Clin Oncol. 2024 Dec;20(2):51-73. doi: 10.14216/kjco.24009. Epub 2024 Dec 31.
3
Unveiling immune cell response disparities in human primary cancer-associated fibroblasts between two- and three-dimensional cultures.
PLoS One. 2024 Dec 19;19(12):e0314227. doi: 10.1371/journal.pone.0314227. eCollection 2024.
4
NK/DC crosstalk-modulating antitumor activity via Sema3E/PlexinD1 axis for enhanced cancer immunotherapy.
Immunol Res. 2024 Dec;72(6):1217-1228. doi: 10.1007/s12026-024-09536-y. Epub 2024 Sep 5.
5
Comparison of Natural Killer Cells Differentiated from Various Pluripotent Stem Cells.
Int J Mol Sci. 2024 Jul 27;25(15):8209. doi: 10.3390/ijms25158209.
6
Enhancing natural killer cells proliferation and cytotoxicity using imidazole-based lipid nanoparticles encapsulating interleukin-2 mRNA.
Mol Ther Nucleic Acids. 2024 Jun 26;35(3):102263. doi: 10.1016/j.omtn.2024.102263. eCollection 2024 Sep 10.
9
CRISPR, CAR-T, and NK: Current applications and future perspectives.
Genes Dis. 2023 Sep 19;11(4):101121. doi: 10.1016/j.gendis.2023.101121. eCollection 2024 Jul.
10
CAR NK92 Cells Targeting BCMA Can Effectively Kill Multiple Myeloma Cells Both In Vitro and In Vivo.
Biomedicines. 2024 Jan 22;12(1):248. doi: 10.3390/biomedicines12010248.

本文引用的文献

2
Advances in clinical NK cell studies: Donor selection, manufacturing and quality control.
Oncoimmunology. 2015 Nov 11;5(4):e1115178. doi: 10.1080/2162402X.2015.1115178. eCollection 2016 Apr.
3
Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity.
Front Immunol. 2015 Nov 30;6:605. doi: 10.3389/fimmu.2015.00605. eCollection 2015.
4
Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer.
Stem Cells. 2016 Jan;34(1):93-101. doi: 10.1002/stem.2230. Epub 2015 Dec 6.
6
NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy.
Front Immunol. 2015 Jul 27;6:368. doi: 10.3389/fimmu.2015.00368. eCollection 2015.
7
NK cells in therapy of cancer.
Crit Rev Oncog. 2014;19(1-2):133-41. doi: 10.1615/critrevoncog.2014011091.
8
Effects of Peptide on NK cell-mediated MHC I recognition.
Front Immunol. 2014 Mar 31;5:133. doi: 10.3389/fimmu.2014.00133. eCollection 2014.
9
Clinical utility of natural killer cells in cancer therapy and transplantation.
Semin Immunol. 2014 Apr;26(2):161-72. doi: 10.1016/j.smim.2014.02.002. Epub 2014 Mar 5.
10
Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance.
J Clin Invest. 2014 Apr;124(4):1810-20. doi: 10.1172/JCI65899. Epub 2014 Feb 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验